Clinical Trials List
Protocol NumberASLAN001-002
2014-05-01 - 2018-02-28
Phase I
Terminated2
-
Trial Applicant
ASLAN PHARMACEUTICALS TAIWAN LIMITED
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2025/08/20
Investigators and Locations
Co-Principal Investigator
- Yi-Chen Yeh Division of Others -
- Chung-Pin Li Digestive System Department
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
12-30 participants
-
Global
12-30 participants
